This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Fenwal, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Gregory Coultas: Innovator in Apheresis Technology
Introduction
Gregory Coultas is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of medical technology, particularly in apheresis procedures. His innovative work has led to the development of systems that enhance the efficiency and effectiveness of blood processing.
Latest Patents
Gregory Coultas holds a patent for "Systems and methods for converting an apheresis fluid processing circuit to single or double needle mode." This patent outlines systems and methods for performing apheresis procedures, including photopheresis. The technology utilizes a disposable fluid circuit that can be converted from a double needle configuration to a single needle configuration and vice versa. A controller directs the action of system pumps to clear potentially stagnant blood residing in the fluid circuit, tracks system parameters and status before and after conversion, and verifies that the procedure may proceed in its new configuration. He has 1 patent to his name.
Career Highlights
Gregory Coultas is currently employed at Fenwal, Inc., a company known for its advancements in blood collection and processing technologies. His work at Fenwal has allowed him to focus on improving patient care through innovative medical solutions.
Collaborations
Gregory has collaborated with talented professionals such as Kevin Schalte and Angela N Carlson. These collaborations have contributed to the development of cutting-edge technologies in the medical field.
Conclusion
Gregory Coultas is a distinguished inventor whose work in apheresis technology has the potential to significantly impact medical procedures. His innovative systems and methods demonstrate a commitment to enhancing patient care and advancing medical technology.